Automated blood cell counts: State of the art

American Journal of Clinical Pathology

Volumn 130, Issue 1, 2008, Pages 104-116

  Buttarello, Mauro ^a   Plebani, Mario ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Blood cell analyzers; CBC count; Immature platelet fraction; Leukocyte differential count; Reticulocyte indices; Reticulocytes

Indexed keywords

ANALYZER; BASOPHIL; BLOOD CELL ANALYZER; BLOOD CELL COUNT; DIAGNOSTIC ACCURACY; ERYTHROBLAST; ERYTHROCYTE; FRAGMENTED RED BLOOD CELL; GRANULOCYTE; HEMATOCRIT; HEMATOPOIETIC STEM CELL; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; MONOCYTE; PARAMETER; PRIORITY JOURNAL; RETICULOCYTE COUNT; REVIEW; THROMBOCYTE COUNT;

AUTOMATION; BLOOD CELL COUNT; CLINICAL LABORATORY TECHNIQUES; ERYTHROBLASTS; ERYTHROCYTE COUNT; GRANULOCYTES; HEMATOLOGY; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; PLATELET COUNT; RETICULOCYTE COUNT;

EID: 48249141136     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/EK3C7CTDKNVPXVTN     Document Type: Review

References (134)

1. Buttarello M. Quality specification in haematology: the automated blood cell count. Clin Chim Acta. 2004;346:45-54.
2. Segal HC, Briggs C, Kunka S, et al. Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. Br J Haematol. 2005;128:520-525.
3. Buttarello M, Bulian P, Farina G, et al. Flow cytometric reticulocyte counting: parallel evaluation of five fully automated analyzers: an NCCLS-ICSH approach. Am J Clin Pathol. 2001;115:100-111.
4. Letestu R, Marzac C, Audat F, et al. Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring. Leuk Lymphoma. 2007;48:89-96.
5. Stolzel F, Oelschlagel U, Holig K, et al. Increased accuracy of HPC quantification using the XE-HPC master technology. Sysmex J Int. 2003;13:83-86.
6. Nigro KG, O'Riordan H, Molloy EJ, et al. Performance of an automated immature granulocyte count as a predictor of neonatal sepsis. Am J Clin Pathol. 2005;123:618-624.
7. Briggs C, Kunka S, Fujimoto H, et al. Evaluation of immature granulocyte counts by the XE-IG Master: upgraded software for the XE-2100 automated hematology analyzer. Lab Hematol. 2003;9:117-124.
8. Ali Ansari-Lari M, Kikler TS, Borowitz MJ. Immature granulocyte measurement using the Sysmex XE-2100. Am J Clin Pathol. 2003;120:795-799.
9. Schaefer M, Rowan RM. The clinical relevance of nucleated red blood cell counts. Sysmex J Int. 2000;10:59-63.
10. Burkett LL, Cox ML, Fields ML. Leukoerythroblastosis in the adult. Am J Clin Pathol. 1996;44:494-498.
11. Stachon A, Holland-Letz T, Krieg M. High in-hospital mortality of intensive care patients with nucleated red blood cells in blood. Clin Chem Lab Med. 2004;48:933-938.
12. Otsubo K, Kaito K, Asai O, et al. Persistent nucleated red blood cells in peripheral blood is a poor prognostic factor in patients undergoing stem cell transplantation. Clin Lab Haematol. 2005;27:242-246.
13. Fosburg MT, Nathan DG. Treatment of Cooley's anemia. Blood. 1990;76:435-444.
14. Hrisinko MA, Curcio K, Gupta R, et al. A comparative evaluation of the Beckman Coulter LH 750 and Sysmex XE 2100 analyzer with regard to identification of NRBC's [abstract]. Int J Lab Hematol. 2007;29(suppl 1):52-53.
15. Buttarello M, Bulian P, Farina G, et al. Five fully automated methods for performing immature reticulocyte fraction: comparison in diagnosis of bone marrow aplasia. Am J Clin Pathol. 2002;117:871-879.
16. Torres Gomez A, Sánchez J, Lakomsky D, et al. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation. Haematologica. 2001;86:24-29.
17. Noronha JFA, De Souza CA, Vigorito AC, et al. Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation. Clin Lab Haematol. 2003;25:47-54.
18. Torres Gomez A, Casano J, Sanchez J, et al. Utility of reticulocyte maturation parameters in the differential diagnosis of macrocytic anemias. Clin Lab Haematol. 2003;25:283-288.
19. Lesesve JF, Daliphard S, Callat MP, et al. Increase of immature reticulocyte fraction in myelodysplastic syndromes [letter]. Clin Lab Haematol. 2004;26:301-302.
20. Remacha AF, Martino R, Sureda A, et al. Changes in the reticulocyte fraction during peripheral stem cell harvesting: role in monitoring stem cell collection. Bone Marrow Transplant. 1996;17:163-168.
21. Dunlop LC, Cohen J, Harvey M, et al. The immature reticulocyte fraction: a negative predictor of the harvesting of CD34 cells for autologous peripheral blood stem cell transplantation. Clin Lab Haematol. 2006;28:245-247.
22. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49:1573-1578.
23. Thomas L, Franck S, Messinger M, et al. Reticulocyte hemoglobin measurement: comparison of two methods in the diagnosis of iron restricted erythropoiesis. Clin Chem Lab Med. 2005;43:1193-1202.
24. Buttarello M, Temporin V, Ceravolo R, et al. The new reticulocyte parameter (Ret-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia. Am J Clin Pathol. 2004;121:489-495.
25. Fishbane S, Shapiro W, Dutka P, et al. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int. 2001;60:2406-2411.
26. Locatelli E, Aljama P, Bárány P, et al; European Best Practice Guidelines Working Group. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl 2):ii1-ii47.
27. KDOQI Clinical Practice Guidelines and Clinical Practice. Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471-530.
28. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res. 1998;28:1-11.
29. 12. Automated Blood Cytol. 1998;13:13-15.
30. d'Onofrio G, Chirillo R, Zini G, et al. Simultaneous measurement of reticulocyte and red cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood. 1995;85:818-823.
31. Parisotto R, Wu M, Ashenden MJ, et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica. 2001;86:128-137.
32. Cappelletti P, Biasioli B, Buttarello M, et al. Mean reticulocyte volume (MCVR): reference intervals and the need for standardization [abstract]. Proceeding of the XIX International Symposium on Technological Innovation in Laboratory Hematology, ISLH. Amsterdam, the Netherlands; April 25-28, 2006:327.
33. Burns ER, Lou Y, Pathak A. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol. 2004;75:18-21.
34. Zini G, Di Mario A, Garzia M. Clinical usefulness of red cell fragments identified by the Sysmex XE-2100 hematological analyser [lecture]. Proceeding of the Sysmex European Haematology Symposium. Lisbon, Portugal; June 13-14, 2007.
35. Lesesve JF, Salignac S, Alla F, et al. Comparative evaluation of schistocyte counting by an automated method and by microscopic determination. Am J Clin Pathol. 2004;121:739-745.
36. Macchi I, Chamlian V, Sadoun A, et al. Comparison of reticulated platelet count and mean platelet volume determination in the evaluation of bone marrow recovery after aplastic chemotherapy. Eur J Haematol. 2002;69:152-157.
37. Briggs C, Kunka S, Hart D, et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol. 2004;126:93-99.
38. Abe Y, Wada H, Tomatsu H, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res. 2006;118:463-469.
39. Chaoui D, Chakroun T, Robert F, et al. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy. Transfusion. 2005;45:766-772.
40. Zucker ML, Murphy CA, Rachel JM, et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol. 2006;12:125-130.
41. Briggs C, Hart D, Kunka S, et al. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med. 2006;16:101-109.
42. Takami A, Shibayama M, Orito M, et al. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;39:501-507.
43. Rinder HM, Schuster JE, Rinder CS, et al. Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood. 1998;91:1288-1294.
44. Panasiuk A, Prokopowicz D, Zak J, et al. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis. Relation to thrombopoietin and hepatocyte growth factor serum concentration. Hepatogastroenterology. 2004;51:1124-1128.
45. International Council for Standardization in Haematology Expert Panel on Cytometry. Guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting and cell marker applications. Clin Lab Haematol. 1994;16:157-174.
46. National Committee for Clinical Laboratory Standards (NCCLS). Reference leukocyte differential count (proportional) and evaluation of instrumental methods; Approved Standard. H2O-A. Villanova, PA: NCCLS; 1992.
47. Kenny D, Fraser CG, Hyltoft Petersen P, et al. Strategies to set global analytical quality specifications in laboratory medicine: consensus agreement [letter]. Scand J Clin Lab Invest. 1999;59:585.
48. Fraser CG, Hyltoft Petersen P. Analytical performance characteristic should be judged against objective quality specifications [editorial]. Clin Chem. 1999;45:321-323.
49. Klee G. A conceptual model for establishing tolerance limits for analytic bias and imprecision based on variations in population test distribution. Clin Chim Acta. 1997;260:175-188.
50. Fraser CG, Hyltoft Petersen P, Libeer JC, et al. Proposal for setting generally applicable quality goals solely based on biology. Ann Clin Biochem. 1997;34:8-12.
51. Statland BE, Winkel P, Harris SC, et al. Evaluation of biologic sources of variation of leukocyte counts and other hematologic quantities using very precise automated analyzer. Am J Clin Pathol. 1977;69:48-54.
52. Richardson Jones A, Twedt D, Swaim W, et al. Diurnal change of blood count analytes in normal subjects. Am J Clin Pathol. 1996;106:723-727.
53. Buttarello M. Variabilità biologica dei parametri ematologici. Riv Med Lab (JLM). 2003;4(suppl 1):88-91.
54. Hyltoft Petersen P, Stockl D, Westgard JO, et al. Models for combining random and systematic errors: assumptions and consequences for different models. Clin Chem Lab Med. 2001;39:581-595.
55. Buttarello M, on behalf of the Hematology Study Group of the Italian Society of Laboratory Medicine. Risultati della sperimentazione multistrumentale in ematologia automatizzata: lo stato dell'arte. Riv Med Lab (JLM). 2004;5(suppl 3):136-141.
56. Sandhaus LM, Osei ES, Agrawal NN, et al. Platelet counting by the Coulter LH 750, Sysmex XE 2100, and ADVIA 120: a comparative analysis using the RBC/platelet ratio reference method. Am J Clin Pathol. 2002;118:235-241.
57. Felle P, McMahon C, Rooney S, et al. Platelets in the paediatric population: the influence of age and the limitation of automation. Clin Lab Haematol. 2005;27:250-257.
58. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood. 1998;91:3601-3606.
59. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusion in adults with acute myeloid leukemia. New Engl J Med. 1997;337:1870-1875.
60. British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10-23.
61. Gmür J, Burger J, Schanz V, et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet. 1991;338:1223-1226.
62. Springer W, Von Ruecker A, Dickeroff R. Difficulties in determining prophylactic transfusion thresholds of platelets in leukemia patients. Blood. 1998;92:2183-2184.
63. Barnes PW, McFadden SL, Machin SJ, et al. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol. 2005;11:83-90.
64. Hoffmann JJML. How useful are haematology analyser flags [editorial]? Clin Chem Lab Med. 2004;42:357-358.
65. International Council for Standardization in Haematology (ICSH). Expert Panel on Cytometry. Recommendation of International Council for Standardization in Haematology on reporting differential leucocyte counts [letter]. Clin Lab Haematol. 1995;17:113.
66. Buttarello M, Gadotti M, Lorenz C, et al. Evaluation of four automated hematology analyzers: a comparative study of differential counts (imprecision and inaccuracy). Am J Clin Pathol. 1992;97:345-352.
67. Rumke CL. Statistical reflections on finding atypical cells. Blood Cells. 1985;11:141-144.
68. Grimaldi E, Carandente P, Scopacasa F, et al. Evaluation of the monocyte counting by two automated haematology analysers compared with flow cytometry. Clin Lab Haematol. 2005;27:91-97.
69. Ducrest S, Meier F, Tschopp C, et al. Flow-cytometric analysis of basophil counts in human blood and inaccuracy of hematology analyzers. Allergy. 2005;60:1446-1450.
70. Houwen B. The differential cell count. Lab Hematol. 2001;7:89-100.
71. Barnett D, Janossy G, Lubenko A, et al. Guideline for the flow cytometric enumeration of CD34+ hematopoietic stem cells. Clin Lab Haematol. 1999;21:301-308.
72. Gratama JW, Sutherland DR, Keeney M, et al. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J Biol Regul Homeost Agents. 2001;15:14-22.
73. Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr. 1988;112:761-767.
74. Seebach JD, Morant R, Ruegg R, et al. The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease. Am J Clin Pathol. 1997;107:582-591.
75. Cornbleet PJ, Novak RW. Lack of reproducibility of band neutrophils identification despite the use of uniform identification criteria. Lab Hematol. 1995;1:89-96.
76. Dutcher TF. Leukocyte differentials: are they worth the effort? Clin Lab Med. 1984;4:71-87.
77. van der Meer W, van Gelder W, de Keijzer R, et al. Does the band cell survive the 21st century? Eur J Haematol. 2006;76:251-254.
78. Fujimoto H, Sakata T, Hamaguchi Y, et al. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry. 2000;42:371-378.
79. Field D, Taube E, Heumann S. Performance evaluation of the immature granulocyte parameter on the Sysmex XE-2100 automated hematology analyzer. Lab Hematol. 2006;12:11-14.
80. Korst LM, Phelan JP, Ahn MO, et al. Nucleated red blood cells: an update on the marker for fetal asphyxia. Am J Obstet Gynecol. 1996;175:843-846.
81. Baschat AA, Gembruch U, Reiss I, et al. Neonatal nucleated red blood cell count and postpartum complications in growth restricted fetuses. J Perinat Med. 2003;31:323-329.
82. Li J. The preliminary study of nucleated red blood cell counting by automated hematology analyzer. Sysmex J Int. 2004;14:13-17.
83. Ruzicka K, Veitl M, Thalhammer-Scherrer R, et al. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med. 2001;125:391-396.
84. De Keijzer MH, van der Meer W. Automated counting of nucleated red blood cells in blood samples of newborns. Clin Lab Haematol. 2002;24:343-345.
85. Gulati G, Behling E, Kocher W, et al. An evaluation of the performance of Sysmex XE-2100 in enumerating nucleated red cells in peripheral blood. Arch Pathol Lab Med. 2007;131:1077-1083.
86. Sher G, Vitisallo B, Schisano D, et al. Automated NRBC count, a new parameter to monitor, in real time, individualized transfusion needs in transfusion-dependent thalassemia major. Lab Hematol. 1997;3:129-137.
87. Heilmeyer L. Blutfarbostoffwechselstudien. Dtsch Arch Klin Med. 1931;171:123-153.
88. Dustin P. Contribution à l'étude histophysiologique et histochimique des globules rouges des vertébrés. Arch Biol (Paris). 1944;55:285-292.
89. Davis BH. Report on the ISLH-sponsored immature reticulocyte fraction (IRF) workshop. Lab Hematol. 1997;3:261-263.
90. Davis BH. Immature reticulocyte fraction (IRF): by any name, a useful clinical parameter of erythropoietic activity. Lab Hematol. 1996;2:2-8.
91. Brugnara C, Colella GM, Cremins JC, et al. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med. 1994;123:660-667.
92. Ullrich C, Wu A, Armsby C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA. 2005;294:924-930.
93. Brecher G, Stohlman F Jr. Reticulocyte size and erythropoietic stimulation. Proc Soc Exp Biol Med. 1961;107:887-891.
94. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28:303-308.
95. Price-Jones C. The variation in sizes of red blood cells. Br Med J. 1910;2:1418-1419.
96. Bessman JD, Gilmer PR, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80:322-326.
97. Flynn MM, Reppun TS, Bhagavan NV. Limitations of red blood cell distribution width (RDW) in evaluation of microcytosis. Am J Clin Pathol. 1986;85:445-449.
98. Simel DL. Is the RDW-MCV classification of anaemia useful? Clin Lab Haematol. 1987;9:349-359.
99. Brittenham GM, Koepke JA. Red blood cell volume distributions and the diagnosis of anemia: help or hindrance? Arch Pathol Lab Med. 1987;111:1146-1148.
100. van den Bossche J, Devreese K, Malfait R, et al. Reference intervals for a complete blood count determined on different automated haematology analysers: ABX Pentra 120 retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer ADVIA 120. Clin Chem Lab Med. 2002;40:69-73.
101. Buttarello M, Toffolo L, Bulian P, et al. Anisocitosi quantitativa (RDW): comparabilità dei risultati ottenuti con le piu recenti tecnologie [abstract]. Riv Med Lab (JLM). 2001;2(suppl 1):163.
102. International Council for Standardization in Haematology. ICSH recommendations for the analysis of red cell, white cell and platelet size distribution curves: methods for fitting a single reference distribution and assessing its goodness of fit. Clin Lab Haematol. 1990;12:417-431.
103. McLaren CE, Houwen B, Koepke JA, et al. Analysis of red blood cell volume distributions using the ICSH reference method: detection of sequential changes in distributions determined by hydrodynamic focusing. Clin Lab Haematol. 1993;15:173-184.
104. Ruutu T, Barosi G, Benjamin RJ, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95-100.
105. Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant. 1995;15:247-253.
106. Klein PG, Pullman H, de Lacroix WF, et al. Quantitative determination of fragment erythrocytes (schistocytes) in healthy subjects and patients after surgery [in German]. Klin Wochenschr. 1975;53:847-851.
107. Lesesve JF, Salignac S, Lecompte T. Laboratory measurement of schistocytes [letter]. Int J Lab Hematol. 2007;29:149-151.
108. Banno S, Ito Y, Tanaka C, et al. Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation. Clin Lab Haematol. 2005;27:292-296.
109. Saigo K, Jiang M, Tanaka C, et al. Usefulness of automatic detection of fragmented red cells using a hematology analyzer for diagnosis of thrombotic microangiopathy. Clin Lab Haematol. 2002;24:347-351.
110. Martin JF, Trowbridge EA, Salmon G, et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32:443-460.
111. Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size and age determine platelet function independently. Blood. 1984;63:1372-1375.
112. Corash L, Chen HY, Levin J, et al. Regulation of thrombopoiesis: effect of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood. 1987;70:177-185.
113. Hoffman R, Long MW. Control of thrombocytopoiesis: current state of the art. Cancer Treat Res. 1995;80:25-49.
114. Bessman JD, Williams LJ, Gilmer PR. Mean platelet volume: the inverse relation of platelet size and count in normal subjects, and an artifact of other particles. Am J Clin Pathol. 1981;76:289-293.
115. Balduini CL, Noris P, Spedini P, et al. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy. Br J Haematol. 1999;106:202-207.
116. Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117:399-404.
117. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991;338:1409-1411.
118. O'Malley T, Langhorne P, Elton RA, et al. Platelet size in stroke patients. Stroke. 1995;26:995-999.
119. Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 2004;35:1688-1691.
120. Hekimsoy Z, Payzin B, Ornek T, et al. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications. 2004;18:173-176.
121. Buttarello M, Lapolla A, Temporin V, et al. Is the platelet size actually index of vascular complications in patients with type 2 diabetes [abstract]? Clin Chem Lab Med. 2007;45:A148.
122. Osselaer JC, Jamrt J, Scheiff JM. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem. 1997;43:1072-1076.
123. International Council for Standardization in Haematology Expert Panel on Cytometry. Recommendation of the International Council for Standardization in Haematology for ethylenediaminetetraacetic acid anticoagulation of blood for blood cell counting and sizing. Am J Clin Pathol. 1993;100:371-372.
124. Bowles KM, Cooke LJ, Richards EM, et al. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol. 2005;27:370-373.
125. Lippi U, Cappelletti P, Schinella M, et al. Mean platelet volumes: facts or artifacts? Am J Clin Pathol. 1985;84:111-113.
126. Trowbridge EA, Reardon DM, Hutchinson D, et al. The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas. 1985;6:22-38.
127. Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol. 1969;17:225-229.
128. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Haematol. 1995;23:996-1001.
129. Rinder HM, Munz VJ, Ault KA, et al. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med. 1993;117:606-610.
130. Matic GB, Chapman SE, Zaiss M, et al. Whole blood analysis of reticulated platelets: improvements of detection and assay stability. Cytometry. 1998;34:229-234.
131. Richards EM, Baglin TP. Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol. 1995;91:445-451.
132. Stohlawetz P, Stiegler G, Knobl P, et al. The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusion. Ann Hematol. 1999;78:271-273.
133. Richards EM, Jestice HK, Mahendra P, et al. Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: implications for marrow reconstitution and the use of thrombopoietin. Bone Marrow Transplant. 1996;17:1029-1033.
134. Bain B. Diagnosis from the blood smear. N Engl J Med. 2005;353:498-507.